Biomedical Engineering Reference
In-Depth Information
[137]
Weil, R. and Israel, A., T cell receptor and B cell receptor mediated activation of
NF-κB in lymphocytes,
Curr. Opin. Immunol.,
16, 1, 2004.
[138]
Wang, D., Matsumoto, R., You, Y.
et al
.
, CD3/CD28 costimulation-induced
NF-kappaB activation is mediated by recruitment of protein kinase C-theta, Bcl10,
and IkappaB kinase beta to the immunological synapse through CARMA1,
Mol. Cell
Biol.,
24, 164, 2004.
[139]
Gaide, O., Favier, B., Legler, D.F. et al., CARMA1 is a critical lipid raft-associated
regulator of TCR-induced NF-kappaB activation,
Nat. Immunol.,
3, 836, 2002.
[140]
Thome, M., CARMA1, BCL-10 and MALT1 in lymphocyte development and acti-
vation,
Nat. Rev. Immunol.,
4, 348, 2004.
[141]
Zhou, H., Wertz, I., O'Rourke, K
et al., Bcl10 activates the NF-κB pathway through
ubiquitination of NEMO,
Nature,
427, 167, 2003.
[142]
Sun, L., Deng, L., Ea, C.-K. et al
.
, The TRAF6 ubiquitin ligase and TAK1 kinase mediate
IKK activation by BCL10 and MALT1 in T lymphocytes,
Mol. Cell,
14, 289, 2004.
[143]
Chiao, P.J., Miyamoto, S., and Verma, I.M., Autoregulation of I kappa B alpha activity,
Proc. Natl. Acad. Sci. USA,
91, 28, 1994.
[144]
Ito, C.Y., Kazantsev, A.G., and Baldwin, A.S., Three NF-kappaB sites in the I kappa
B-alpha promoter are required for induction of gene expression by TNF alpha,
Nuc.
Acid Res.,
22, 3787, 1994.
[145]
Scott, M.L., Fujita, T., Liou, H.C. et al., The p65 subunit of NF-kappaB regulates I
kappa B by two distinct mechanisms,
Genes Dev.,
7, 1266, 1993.
[146]
Arenzana-Seisdedos, F., Thompson, J., Rodriguez, M. et al., Inducible nuclear expres-
sion of newly synthesized I kappa B alpha negatively regulates DNA-binding and
transcriptional activities of NF-kappaB,
Mol. Cell. Biol.,
15, 2689, 1995.
[147]
Arenzana-Seisdedos, F., Turpin, P., Rodriguez, M.
et al
.
, Nuclear localization of
IkappaBalpha promotes active transport of NF-kappaB from the nucleus to the cyto-
plasm,
J. Cell Sci.,
110, 369, 1997.
[148]
Tam, W.F., Lee, L.H., Davis, L.
et al., Cytoplasmic sequestration of rel proteins by
IκBα requires CRM1-dependent nuclear export,
Mol. Cell. Biol.,
20, 2269, 2000.
[149]
Bignell, G.R., Warren, W., Seal, S.
et al
.
, Identification of the familial cylindromatosis
tumour-suppressor gene,
Nat. Genet.,
25, 160, 2000.
[150]
Kovalenko, A., Chable-Bessia, C., Cantarella, G. et al., The tumour suppressor CYLD
negatively regulates NF-κB signalling by deubiquitination,
Nature,
424, 801, 2003.
[151]
Trompouki, E., Hatzivassiliou, E., Tsichritzis, T. et al., CYLD is a deubiquitinating
enzyme that negatively regulates NF-κB activation by TNFR family members,
Nature,
424, 793, 2003.
[152]
Brummelkamp, T.R., Nijman, S.M.B., Dirac, A.M.G.
et al
.
, Loss of the cylindromatosis
tumour suppressor inhibits apoptosis by activating NF-κB,
Nature,
424, 797, 2003.
[153]
Reiley, W., Zhang, M., and Sun, S.-C., Negative regulation of JNK signaling by the
tumor suppressor CYLD,
J. Biol. Chem.,
279, 55161, 2004.
[154]
Habelhah, H., Takahashi, S., Cho, S.G.
et al
.
, Ubiquitination and translocation of
TRAF2 is required for activation of JNK but not p38 or NF-κB,
Embo J.,
23, 322, 2004.
[155]
Reiley, W., Zhang, M., Xuefeng, W.
et al., Regulation of the deubiquitinating enzyme
CYLD by IκB kinase gamma-dependent phosphorylation,
Mol. Cell. Biol.,
25, 3886,
2005.
[156]
Jono, H., Lim, J.H., Chen, L.-F. et al., NF-κB is essential for induction of CYLD,
the negative regulator of NF-κB,
J. Biol. Chem.,
279, 36171, 2004.
[157]
Beyaert, R., Heyninck, K., and van Huffel, S., A20 and A20-binding proteins as
cellular inhibitors of nuclear factor-κB-dependent gene expression and apoptosis,
Biochem. Pharm.,
60, 1143, 2000.
